Treatment of Amenorrhea (absence of monthly menstrual periods) by Unani medicine Habb-e-Mudir

Clinical Validation of Unani Pharmacopoeial Formulation Habb-e-Mudir in IhÌ£tibÄ?s al-Tamth (Amenorrhea)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/02/017786

Enrollment

240

Registered

2019-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N911- Secondary amenorrhea

Interventions

Intervention1: Habb-e-Mudir: 1 Tab orally thrice daily after meals with water for 5 days from expected date of menses for 3 months Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: 1. Married /unmarried patients in the age group of 18-40 years. 2. Patients with secondary amenorrhoea.

Exclusion criteria

Exclusion criteria: 1. Patients with Primary Amenorrhea and primary ovarian failure 2. Patients with Hyperprolactinaemia 3. Patients with any systemic illness and malignancy 4. Pregnant and lactating woman 5. Known cases of bleeding disorders 6. Patients taking OCPâ??s / IUCD

Design outcomes

Primary

Measure	Time frame
Improvement in signs and symptoms of IhÌ£tibÄ?s al-Tamth (Amenorrhea)Timepoint: 3 months	—

Secondary

Measure	Time frame
Haematological and biochemical assessment for safety assessmentTimepoint: Investigations will be done at baseline and end of treatment	—

Countries

India

Contacts

Public ContactDr Pradeep Kumar

Central Council for Research in Unani Medicine (CCRUM)

ccrum507@rediffmail.com9213511298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026